Bosh sahifa1276 • HKG
add
Jiangsu Hengrui Pharmaceuticals Co Ltd
Yopilish kursi
82,00 $
Kunlik diapazon
77,80 $ - 82,70 $
Yillik diapazon
52,50 $ - 95,20 $
Bozor kapitalizatsiyasi
445,58 mlrd HKD
Oʻrtacha hajm
4,35 mln
Narx/foyda
64,76
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 8,56 mlrd | 12,53% |
Joriy xarajat | 4,88 mlrd | 7,13% |
Sof foyda | 2,58 mlrd | 24,88% |
Sof foyda marjasi | 30,11 | 10,98% |
Har bir ulushga tushum | — | — |
EBITDA | 2,82 mlrd | 22,24% |
Amaldagi soliq stavkasi | 13,35% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 36,23 mlrd | 55,59% |
Jami aktivlari | 62,89 mlrd | 30,53% |
Jami passivlari | 3,86 mlrd | -22,64% |
Umumiy kapital | 59,03 mlrd | — |
Tarqatilgan aksiyalar | 6,47 mlrd | — |
Narxi/balansdagi bahosi | 9,07 | — |
Aktivlardan daromad | 11,49% | — |
Kapitaldan daromad | 12,29% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 2,58 mlrd | 24,88% |
Operatsiyalardan naqd pul | 3,75 mlrd | 110,63% |
Sarmoyadan naqd pul | -553,06 mln | 28,47% |
Moliyadan naqd pul | 8,70 mlrd | 7 324,40% |
Naqd pulning sof oʻzgarishi | 11,91 mlrd | 1 228,08% |
Boʻsh pul | 3,01 mlrd | 6,79% |
Haqida
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Tashkil etilgan
28-apr, 1997
Sayt
Xodimlar soni
20 560
